Serial 99467602
Live / Allowed — Publication / registration review complete (as of 18 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99467602
- Mark type
- Design / logo
- Filed
- 28 Oct 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Alexander Ruzzier
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, elixirs for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Pharmaceutical preparations for the prevention of cardiovascular and cerebrovascular diseases, hematologic disorders, dermatological diseases, ophthalmic diseases, gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, respiratory system diseases, digestive system diseases, endocrine system diseases, immune system diseases, musculo-skeletal system diseases, and hypersensitivity diseases; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Medicines made of Chinese traditional medicinal herbs; Vaccines for human use; Insulin; Dietetic foods adapted for medical use; Veterinary pharmaceutical preparations for the treatment of cardiovascular and cerebrovascular diseases, hematologic disorders, dermatological diseases, ophthalmic diseases, gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, respiratory system diseases, digestive system diseases, endocrine system diseases, immune system diseases, musculo-skeletal system diseases, and hypersensitivity diseases; Animal feed additive for use as a nutritional supplement for medical purposes
Owner
- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD., Shenzhen, Guangdong, CN
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Mar 2026 — ASSIGNED TO EXAMINER
- 09 Mar 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 09 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Oct 2025 — NEW APPLICATION ENTERED